Only 2 weeks to go until the 2024 ARCS Australia Annual Conference at the ICC, Sydney on 12-14 June. This year, the ARCS Annual Conference theme is “The Future of Medicine: The confluence of devices, drugs and data”, featuring a comprehensive program with parallel sessions spanning three days.

Our Director, Sarah Griffin is looking forward to attending the conference as well as Chairing SESSION B06 – The ABC’s of Regulatory and Reimbursement in the US Market Thursday 13 June at 11:15am. This session has 2 experts in US regulatory and reimbursement, Michelle Lott, Principal and Founder, leanRAQA and Nic Anderson Principal and Founder, N C Anderson Consulting.

It will include invaluable information for companies interested in exploring the complex US market.

  • Where do you even begin as a medical device start-up for commercialisation in the US market – regulatory or reimbursement?
  • For a start-up, regulatory and reimbursement are the foundation of a solid business plan.


Sarah added “As I frequently work with SME’s, I know the importance of getting local advice, so I am very excited to be chairing a session with two US experts, Michelle Lott and Nick Anderson who will discuss the basics of regulatory and reimbursement before entering the US market”.


Find out more about the 2024 ARCS Annual Conference and register HERE